tradingkey.logo
tradingkey.logo
検索

Bausch + Lomb Corp

BLCO
ウォッチリストに追加
16.540USD
-0.090-0.54%
終値 06/30, 16:00ET15分遅れの株価
5.86B時価総額
損失額直近12ヶ月PER

詳細情報 Bausch + Lomb Corp 企業名

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Bausch + Lomb Corpの企業情報

企業コードBLCO
会社名Bausch + Lomb Corp
上場日May 06, 2022
最高経営責任者「CEO」Saunders (Brenton L)
従業員数13500
証券種類Ordinary Share
決算期末May 06
本社所在地520 Applewood Crescent
都市VAUGHAN
証券取引所NASDAQ OMX NASDAQ Basic NYSE
Canada
郵便番号L4K 4B4
電話番号19082552864
ウェブサイトhttps://ir.bausch.com/
企業コードBLCO
上場日May 06, 2022
最高経営責任者「CEO」Saunders (Brenton L)

Bausch + Lomb Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--
Mrs. Nathalie Bernier
Mrs. Nathalie Bernier
Independent Director
Independent Director
--
--
Dr. Andrew Charles Von Eschenbach, M.D.
Dr. Andrew Charles Von Eschenbach, M.D.
Independent Director
Independent Director
--
--
Ms. Sarah B. Kavanagh
Ms. Sarah B. Kavanagh
Independent Director
Independent Director
--
--
Mr. John A. Paulson ,
Mr. John A. Paulson ,
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Luc Bonnefoy
Mr. Luc Bonnefoy
President - Surgical
President - Surgical
87.02K
-1.16%
Dr. Yehia Hashad, M.D.
Dr. Yehia Hashad, M.D.
Executive Vice President - Research & Development, Chief Medical Officer
Executive Vice President - Research & Development, Chief Medical Officer
72.80K
-18.77%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
57.52K
+62.90%
Mr. Russel C. Robertson
Mr. Russel C. Robertson
Independent Director
Independent Director
27.66K
+57.27%
Mr. Sam A. Eldessouky
Mr. Sam A. Eldessouky
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Thomas W. Ross, Sr.
Mr. Thomas W. Ross, Sr.
Lead Independent Director
Lead Independent Director
--
--

よくある質問

Bausch + Lomb Corpの上位5名の株主は誰ですか?

Bausch + Lomb Corpの上位5名の株主は以下のとおりです。Mr. Luc Bonnefoy

Bausch + Lomb Corp(BLCO)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Bausch + Lomb Corpの株式を保有している機関は249社あり、保有株式の総市場価値は約40.30Mで、全体の11.30%を占めています。2025Q4と比較して、機関の持ち株は-25007155.00増加しています。

Bausch + Lomb Corpの最大の収益源は何ですか?

2026Q1において、Devices部門がBausch + Lomb Corpにとって最大の収益を生み出しており、その金額は1.92Bで、全収益の37.68%を占めています。
KeyAI